http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2392001-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-54
filingDate 2008-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a108f43da8403c90b1749253155feaa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7374f09daa3e016bd53ddd10daa5198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f88e1b2c752b88ffe1243da5ef5e73
publicationDate 2010-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2392001-C2
titleOfInvention Icteric form of hepatitis a in childen with food allergy treatment method
abstract FIELD: medicine. n SUBSTANCE: invention belongs to medicine, notably to hepatology, and relates to viral hepatitis A treatment in children with food allergy in acute phase of disease. On admission to hospital patient receives usual complex therapy of hepatitis, complemented with antihistaminic drugs - suprastin or tavegil, and enzymatic drugs - pancreatin or mesym - forte. Suprastin or tavegil is administered ј - 1 tablet after meal two times a day during 7-10 days. Pancreatin or mezym-forte is administered Ѕ-1 tablet 3 times a day during 14-18 days. n EFFECT: method fastens children recovery and reduces frequency of disease residual effects. n 1 ex, 6 tbl, 4 dwg
priorityDate 2008-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25295
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26987
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12092

Total number of triples: 30.